255 related articles for article (PubMed ID: 10477434)
21. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
22. Late-onset globoid cell leucodystrophy (Krabbe's disease). Clinical and genetic delineation of two forms and their relation to the early-infantile form.
Loonen MC; Van Diggelen OP; Janse HC; Kleijer WJ; Arts WF
Neuropediatrics; 1985 Aug; 16(3):137-42. PubMed ID: 4047347
[TBL] [Abstract][Full Text] [Related]
23. Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation.
Xu C; Sakai N; Taniike M; Inui K; Ozono K
J Hum Genet; 2006; 51(6):548-554. PubMed ID: 16607461
[TBL] [Abstract][Full Text] [Related]
24. Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy.
De Gasperi R; Gama Sosa MA; Sartorato EL; Battistini S; MacFarlane H; Gusella JF; Krivit W; Kolodny EH
Am J Hum Genet; 1996 Dec; 59(6):1233-42. PubMed ID: 8940268
[TBL] [Abstract][Full Text] [Related]
25. Adult-onset Krabbe's disease in siblings with novel mutations in the galactocerebrosidase gene.
Bernardini GL; Herrera DG; Carson D; DeGasperi R; Gama Sosa MA; Kolodny EH; Trifiletti R
Ann Neurol; 1997 Jan; 41(1):111-4. PubMed ID: 9005874
[TBL] [Abstract][Full Text] [Related]
26. Expression of individual mutations and haplotypes in the galactocerebrosidase gene identified by the newborn screening program in New York State and in confirmed cases of Krabbe's disease.
Saavedra-Matiz CA; Luzi P; Nichols M; Orsini JJ; Caggana M; Wenger DA
J Neurosci Res; 2016 Nov; 94(11):1076-83. PubMed ID: 27638593
[TBL] [Abstract][Full Text] [Related]
27. Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy.
Chen YQ; Rafi MA; de Gala G; Wenger DA
Hum Mol Genet; 1993 Nov; 2(11):1841-5. PubMed ID: 8281145
[TBL] [Abstract][Full Text] [Related]
28. A novel homozygous GALC mutation: very early onset and rapidly progressive Krabbe disease.
Kardas F; Uzak AS; Hossain MA; Sakai N; Canpolat M; Yıkılmaz A
Gene; 2013 Mar; 517(1):125-7. PubMed ID: 23276707
[TBL] [Abstract][Full Text] [Related]
29. Globoid cell leukodystrophy (Krabbe's disease): update.
Suzuki K
J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
[TBL] [Abstract][Full Text] [Related]
30. Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy.
Lee WC; Tsoi YK; Troendle FJ; DeLucia MW; Ahmed Z; Dicky CA; Dickson DW; Eckman CB
FASEB J; 2007 Aug; 21(10):2520-7. PubMed ID: 17403939
[TBL] [Abstract][Full Text] [Related]
31. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.
Lee WC; Kang D; Causevic E; Herdt AR; Eckman EA; Eckman CB
J Neurosci; 2010 Apr; 30(16):5489-97. PubMed ID: 20410102
[TBL] [Abstract][Full Text] [Related]
33. Compound Galactosylceramidase Gene (GALC) Heterozygosity in a Boy with Infantile Krabbe Disease (KD).
Gucev Z; Tasic V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(3):99-101. PubMed ID: 27442402
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of ARSA mutations in a Chinese family with metachromatic leukodystrophy].
Wang JM; Jiang YW; Shi HP; Zhang WM; Pan H; Bao XH; Wu Y; Qin J; Wu XR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):378-82. PubMed ID: 16883521
[TBL] [Abstract][Full Text] [Related]
35. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
36. Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.
Krägeloh-Mann I; Harzer K; Rostásy K; Beck-Wödl S; Bornemann A; Böhringer J; Bevot A; Beck V; Merkel G; Pechan M
Eur J Paediatr Neurol; 2017 May; 21(3):522-529. PubMed ID: 28109651
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment.
Sakai N
Brain Dev; 2009 Aug; 31(7):485-7. PubMed ID: 19332366
[TBL] [Abstract][Full Text] [Related]
38. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
[TBL] [Abstract][Full Text] [Related]
39. Protracted course of Krabbe disease in an adult patient bearing a novel mutation.
Jardim LB; Giugliani R; Pires RF; Haussen S; Burin MG; Rafi MA; Wenger DA
Arch Neurol; 1999 Aug; 56(8):1014-7. PubMed ID: 10448809
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease.
Tappino B; Biancheri R; Mort M; Regis S; Corsolini F; Rossi A; Stroppiano M; Lualdi S; Fiumara A; Bembi B; Di Rocco M; Cooper DN; Filocamo M
Hum Mutat; 2010 Dec; 31(12):E1894-914. PubMed ID: 20886637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
